NCT04229225View on ClinicalTrials.gov

A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 23, 2020

Primary Completion Date

September 18, 2020

Study Completion Date

September 18, 2020

Conditions

Knee Osteoarthritis

Interventions

DRUG

UBX0101

Investigational drug intra-articular (IA) injection

OTHER

Placebo

Placebo intra-articular (IA) injection

Trial Locations (7)

14609

Rochester Clinical Research, Inc., Rochester

29406

Arcis Healthcare LLC dba Lowcountry Orthopaedics and Sports Medicine, North Charleston

30060

Drug Studies America, Marietta

32159

Premier Medical Associates, The Villages

63141

Sundance Clinical Research, LLC, St Louis

77401

First Surgical Hospital, Bellaire

08009

Hassman Research Institute, Berlin

All Listed Sponsors

lead

Unity Biotechnology, Inc.

INDUSTRY

NCT04229225 - A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter